HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment
about
Women Who Use or Inject Drugs: An Action Agenda for Women-Specific, Multilevel, and Combination HIV Prevention and ResearchOperational feasibility of using whole blood in the rapid HIV testing algorithm of a resource-limited settings like Bangladesh.Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.Correlates of Injection Drug Use Among Rural Appalachian Women.Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine.Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study.Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study."They accept me, because I was one of them": formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal.HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system.Preoperative screening for illicit drug use in patients undergoing emergency surgery: A prospective observational study.
P2860
Q28083693-E24E0FDF-8205-4476-BC04-13701BF97A0EQ36675751-02C9C675-E078-4731-8003-99D92192DADBQ40048259-31513E60-51E9-43E9-8970-DE44C64F1590Q40144468-1EE33B9D-6F68-4836-AF45-58C15A3E7FB9Q40286008-33EDB74B-E8F5-4081-9B17-8EA333995F73Q40537570-0FB6CC23-2568-41B7-B807-D4ECB8B247DAQ42720607-9DB27F6F-2991-4F47-857F-3B0DF01F482CQ44350723-FCBED8D8-3696-4991-A4CE-6348C88C5830Q47565629-EA7A262B-1BC0-46DE-B34C-4B480993277CQ47577981-4213891F-9542-4113-9049-8748BFD6C636Q48096212-25DA3D56-03A0-4B2A-A9D2-E9A2F96D7B69Q51744232-CFB2D6CE-B194-478D-9D0D-B7FF59B879EDQ51746853-EEFF84EF-044C-4AAE-B4BD-6705D0CC0E24Q52661345-C7BECD48-63A5-441E-8F56-0C8A760E7D9AQ55314184-AABD1F1F-1FBF-4550-86F4-BF7911CD6424
P2860
HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@ast
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@en
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@nl
type
label
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@ast
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@en
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@nl
prefLabel
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@ast
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@en
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@nl
P2093
P2860
P1476
HIV, HCV, and Health-Related H ...... s for Prevention and Treatment
@en
P2093
Annie Madden
Jenny Iversen
Kimberly Page
P2860
P304
P356
10.1097/QAI.0000000000000659
P407
P478
69 Suppl 2
P50
P577
2015-06-01T00:00:00Z